1Hentze, MW, Muckenthaler, MU, Galy, B, et al. (2010) Two to tango: regulation of mammalian iron metabolism. Cell 142, 24–38.
2Bertelsen, M, Anggard, EE & Carrier, MJ (2001) Oxidative stress impairs insulin internalization in endothelial cells in vitro. Diabetologia 44, 605–613.
3Fernandez-Real, JM, Lopez-Bermejo, A & Ricart, W (2002) Cross-talk between iron metabolism and diabetes. Diabetes 51, 2348–2354.
4McClain, DA, Abraham, D, Rogers, J, et al. (2006) High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia 49, 1661–1669.
5Nemeth, E, Tuttle, MS, Powelson, J, et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093.
6Bridle, KR, Frazer, DM, Wilkins, SJ, et al. (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669–673.
7Roetto, A, Papanikolaou, G, Politou, M, et al. (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33, 21–22.
8Nemeth, E, Roetto, A, Garozzo, G, et al. (2005) Hepcidin is decreased in TFR2 hemochromatosis. Blood 105, 1803–1806.
9Hunter, HN, Fulton, DB, Ganz, T, et al. (2002) The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 277, 37597–37603.
10Jiang, R, Manson, JE, Meigs, JB, et al. (2004) Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291, 711–717.
11Forouhi, NG, Harding, AH, Allison, M, et al. (2007) Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 50, 949–956.
12Fernandez-Real, JM, Equitani, F, Moreno, JM, et al. (2009) Study of circulating prohepcidin in association with insulin sensitivity and changing iron stores. J Clin Endocrinol Metab 94, 982–988.
13Bekri, S, Gual, P, Anty, R, et al. (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131, 788–796.
14Aso, Y, Takebayashi, K, Wakabayashi, S, et al. (2010) Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes. Diabetes Res Clin Pract 90, 250–255.
15Jiang, F, Sun, ZZ, Tang, YT, et al. (2011) Hepcidin expression and iron parameters change in type 2 diabetic patients. Diabetes Res Clin Pract 93, 43–48.
16Kulaksiz, H, Gehrke, SG, Janetzko, A, et al. (2004) Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53, 735–743.
17Hadley, KB, Johnson, LK & Hunt, JR (2006) Iron absorption by healthy women is not associated with either serum or urinary prohepcidin. Am J Clin Nutr 84, 150–155.
18Piperno, A, Girelli, D, Nemeth, E, et al. (2007) Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 110, 4096–4100.
19Roe, MA, Spinks, C, Heath, AL, et al. (2007) Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women. Br J Nutr 97, 544–549.
20Utzschneider, KM & Kowdley, KV (2010) Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol 6, 26–33.
21Young, MF, Glahn, RP, Ariza-Nieto, M, et al. (2009) Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women. Am J Clin Nutr 89, 533–538.
22Frazer, DM & Anderson, GJ (2009) Hepcidin compared with prohepcidin: an absorbing story. Am J Clin Nutr 89, 475–476.
23Liu, Y, Zhou, D, Zhang, Z, et al. (2011) Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population. J Lipid Res 52, 354–360.
24Ferrucci, L, Semba, RD, Guralnik, JM, et al. (2010) Proinflammatory state, hepcidin, and anemia in older persons. Blood 115, 3810–3816.
25Ganz, T, Olbina, G, Girelli, D, et al. (2008) Immunoassay for human serum hepcidin. Blood 112, 4292–4297.
26Shi, Z, Hu, X, Yuan, B, et al. (2006) Association between serum ferritin, hemoglobin, iron intake, and diabetes in adults in Jiangsu, China. Diabetes Care 29, 1878–1883.
27Dallalio, G, Fleury, T & Means, RT (2003) Serum hepcidin in clinical specimens. Br J Haematol 122, 996–1000.
28Vari, IS, Balkau, B, Kettaneh, A, et al. (2007) Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 30, 1795–1801.
29You, SA & Wang, Q (2005) Ferritin in atherosclerosis. Clin Chim Acta 357, 1–16.
30Sun, L, Franco, OH, Hu, FB, et al. (2008) Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab 93, 4690–4696.
31Sharifi, F, Ziaee, A, Feizi, A, et al. (2010) Serum ferritin concentration in gestational diabetes mellitus and risk of subsequent development of early postpartum diabetes mellitus. Diabetes Metab Syndr Obes 3, 413–419.
32Hanley, AJ, Williams, K, Festa, A, et al. (2004) Elevations in markers of liver injury and risk of type 2 diabetes: The Insulin Resistance Atherosclerosis Study. Diabetes 53, 2623–2632.